First AD

Second AD

Ovarian Cancer

GSK-22-OSD1278 - /clinical/ovarian-cancer

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Oncology Nursing News

The OncLive Nursing News condition center page is a comprehensive resource for clinical news and expert insights for oncology nurses and their best practices for treating patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research across malignancies that can be beneficial for oncology nurses.

Supportive Care

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Immuno-Oncology

Managing Treatment Decisions for Ovarian Cancer

Insights

Platinum Sensitivity and PARP Inhibition in Ovarian Cancer

Ovarian Cancer: Talking to Patients About PARP Inhibitors

Options With Genetic Testing in Ovarian Cancer

Ovarian Cancer: Making Treatment Plans Together

Talking With Patients About Recurrence Risk in Ovarian Cancer

Ovarian Cancer Decisions: Treatment Versus Maintenance

Ovarian Cancer: Deciding Among PARP Inhibitors

PARP Inhibitor Side Effect Management in Ovarian Cancer

Evolving Role of PARP Inhibitors in Ovarian Cancer

Unmet Needs in Ovarian Cancer